Yow Keat is a Group Leader and Baker-La Trobe Senior Research Fellow in the Metabolomics laboratory. He currently leads the Cardiovascular Lipidomics and Therapeutics program, where his research utilises lipidomics, molecular biology and imaging techniques to understand cardiovascular disease using preclinical models. This ultimately is aimed at development of innovative lipid modulating therapies to treat cardiovascular and other chronic diseases.

Yow Keat was awarded his PhD in Medicine from Monash University in 2018. He conducted his doctoral research under the guidance of Professor Julie McMullen and Professor Peter Meikle, and completed his first postdoctoral stint under Professor Julie McMullen (2018–2022) During his PhD, he demonstrated distinctive lipid profiles in the heart and circulation following exercise vs heart failure/disease, and how modulating different lipid species in the heart could affect cardiac health. His postdoctoral research further focused on the role of specific lipids in cardioprotection and heart disease, whether the manipulation of these lipids can serve as new therapies for heart failure and how changes to the heart can affect systemic change to lipids in other tissues. His findings were published in top journals including Nature Communications, Cell Reports and Diabetes.

Yow Keat is highly active within the scientific community, having co-chaired the Early Career Researcher committees within the Baker Institute, and the International Society for Heart Research (ISHR) Australasian and International sections. He currently also serves in multiple committees within the Baker Institute.